基于精密纳米瘤学的向治疗和智能输送系统的进步
Ji Ma1, Chao Fu Zhao2, Xinyang Liu3
1Department of Gastrointestinal surgery, Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
International immunopharmacology
|December 13, 2025
概括
纳米技术正在通过精确的纳米医学彻底改变癌症治疗,提供有针对性的药物输送,克服传统治疗的限制. 未来的应用将集成先进的疗法,但面临着诸如瘤异质性和制造等挑战.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 传统的癌症疗法面临的局限性包括缺乏特异性和显著的副作用.
- 纳米技术为开发有针对性和个性化的癌症治疗提供了新的平台.
- 精密瘤学旨在根据个体患者和瘤特征量身定制治疗方法.
研究的目的:
- 审查用于癌症治疗的纳米治疗的最新进展.
- 突出纳米载体在向药物输送和控制释放中的作用.
- 讨论纳米技术与新兴的癌症治疗模式和相关挑战的整合.
主要方法:
- 对精密瘤学中纳米技术的当前文献的综述.
- 纳米载体设计的分析,包括被动 (EPR效应) 和主动准.
- 讨论刺激响应的纳米载体系统,以增强时空药物释放.
- 探索纳米技术与免疫疗法,光热/光动力疗法,基因编辑和超神学的整合.
主要成果:
- 纳米载体促进了向药物输送,提高了疗效,减少了副作用.
- 刺激响应系统能够在瘤微环境中准确释放药物.
- 与免疫疗法和基因编辑等其他方式的整合显示出显著的治疗潜力.
- 挑战包括瘤异质性,免疫逃避,制造可扩展性和监管障碍.
结论:
- 纳米技术对精确的癌症纳米医学具有变革性的潜力,提供个性化和最少侵入性的治疗策略.
- 克服交付,制造和监管方面的挑战对于临床翻译至关重要.
- 持续的研究和开发对于充分实现纳米医学在瘤学中的承诺至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drug Delivery: Overview
701
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
701
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


